抗COX-2自身抗体是免疫性再生障碍性贫血的新型生物标志物
在免疫性再生障碍性贫血(IAA)中,严重全血细胞减少由免疫介导的造血干细胞破坏引起。研究者用含超过9000种蛋白的微阵列筛选自身抗体,并在405例IAA患者和815例对照中验证,发现一种结合环氧化酶2(COX-2)C末端的自身抗体(aCOX-2 Ab)。37%的成人IAA患者该抗体阳性,而对照组仅1.7%阳性。
要点
- 37%的成人IAA患者aCOX-2 Ab阳性,对照组仅1.7%阳性。
- aCOX-2 Ab阳性与年龄和HLA-DRB1*15:01基因型相关。
- 超过40岁且携带HLA-DRB1*15:01的IAA患者中83%为aCOX-2 Ab阳性。
核心结论
- 结果提示aCOX-2 Ab定义了IAA的一个独特亚组,并可能作为有价值的疾病生物标志物。
研究设计与样本
- 使用含超过9000种蛋白的微阵列筛选自身抗体,并在大型国际队列的IAA患者(n=405)和对照(n=815)中验证。
主要发现
- 37%的成人IAA患者aCOX-2 Ab阳性,而对照组仅1.7%阳性。
- 在相关骨髓衰竭疾病、多发性硬化和1型糖尿病患者中观察到散发的非IAA aCOX-2 Ab阳性病例,而健康对照、非自身炎症性疾病或类风湿关节炎患者中未检测到aCOX-2 Ab血清阳性。
- 在IAA中,抗COX-2 Ab阳性与年龄和HLA-DRB1*15:01基因型相关。
- 超过40岁且携带HLA-DRB1*15:01的IAA患者中83%为抗COX-2 Ab阳性。
- aCOX-2 Ab阳性的IAA患者还表现为更低的血小板计数。
关键数值与推荐
- 37%的成人IAA患者aCOX-2 Ab阳性 vs 对照组1.7%阳性。
- 超过40岁且携带HLA-DRB1*15:01的IAA患者中83%为抗COX-2 Ab阳性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In immune aplastic anemia (IAA), severe pancytopenia results from the immune-mediated destruction of hematopoietic stem cells. Several autoantibodies have been reported, but no clinically applicable autoantibody tests are available for IAA. We screened autoantibodies using a microarray containing >9000 proteins and validated the findings in a large international cohort of IAA patients (n = 405) and controls (n = 815). We identified a novel autoantibody that binds to the C-terminal end of cyclooxygenase 2 (COX-2, aCOX-2 Ab). In total, 37% of all adult IAA patients tested positive for aCOX-2 Ab, while only 1.7% of the controls were aCOX-2 Ab positive. Sporadic non-IAA aCOX-2 Ab positive cases were observed among patients with related bone marrow failure diseases, multiple sclerosis, and type I diabetes, whereas no aCOX-2 Ab seropositivity was detected in the healthy controls, in patients with non-autoinflammatory diseases or rheumatoid arthritis. In IAA, anti-COX-2 Ab positivity correlated with age and the HLA-DRB1*15:01 genotype. 83% of the >40 years old IAA patients with HLA-DRB1*15:01 were anti-COX-2 Ab positive, indicating an excellent sensitivity in this group. aCOX-2 Ab positive IAA patients also presented lower platelet counts. Our results suggest that aCOX-2 Ab defines a distinct subgroup of IAA and may serve as a valuable disease biomarker.
引用
- Kelkka T, Tyster M, Lundgren S, et al. Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia. Leukemia. 2022. PMID: 35927326. doi:10.1038/s41375-022-01654-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。